PlumeStars and Biopharmanet-Tec will attend together with the company Lisapharma spa The Eight World Congress of Orphan Medicines, in Barcelona on 14 and 15 November 2017.
The Congress brings together companies, start-ups and stakeholders in the field of orphan diseases and rare diseases. It is a key meeting for the orphan medicines companies. PlumeStars. Biopharmanet and Lisapharma will present their EMA and FDA designed orphan medicines. They are:
- Respirable powder of amikacin for lung infections in cystic fibrosis patients;
- Cisplatin hyaluronic film for implant to prevent relapse after pleural mesothelioma removal;
- Oral and nasal powder of thalidomide foe epistaxis in telangiectasia;
- Nanomedicine of zoledronic acid for treatment of glioblastoma.
Together with Lisapharma and PlumeStars, more than 400 companies will be present, presenting their projects Genzyme, GSK, Pfizer, Roche, Alexion, Prometic, Takeda, BMS, Abbvie, Biogen, Bluebird.
